Please ensure Javascript is enabled for purposes of website accessibility
ホーム > 製品 > 抗体 > バイオシミラー

Anti-Human CD371/CLEC12A & CD3 epsilon Bispecific Reference Antibody (Tepoditamab, RUO) (HV493016)

Anti-Human CD371/CLEC12A & CD3 epsilon Bispecific Reference Antibody (Tepoditamab, RUO)
Anti-Human CD371/CLEC12A & CD3 epsilon Bispecific Reference Antibody (Tepoditamab, RUO)
Anti-Human CD371/CLEC12A & CD3 epsilon Bispecific Reference Antibody (Tepoditamab, RUO)
Anti-Human CD371/CLEC12A & CD3 epsilon Bispecific Reference Antibody (Tepoditamab, RUO)
Anti-Human CD371/CLEC12A & CD3 epsilon Bispecific Reference Antibody (Tepoditamab, RUO)
Anti-Human CD371/CLEC12A & CD3 epsilon Bispecific Reference Antibody (Tepoditamab, RUO)
Anti-Human CD371/CLEC12A & CD3 epsilon Bispecific Reference Antibody (Tepoditamab, RUO)
Anti-Human CD371/CLEC12A & CD3 epsilon Bispecific Reference Antibody (Tepoditamab, RUO)
Anti-Human CD371/CLEC12A & CD3 epsilon Bispecific Reference Antibody (Tepoditamab, RUO)
Anti-Human CD371/CLEC12A & CD3 epsilon Bispecific Reference Antibody (Tepoditamab, RUO)
Anti-Human CD371/CLEC12A & CD3 epsilon Bispecific Reference Antibody (Tepoditamab, RUO)
Anti-Human CD371/CLEC12A & CD3 epsilon Bispecific Reference Antibody (Tepoditamab, RUO)
価格(USD):
スペック:
  • 100ug
  • 1mg
  • 5mg
  • 10mg
  • 25mg
  • 50mg
  • 100mg
数量:
お問い合わせ
  • 概要

  • イメージ

  • 参考文献

  • データシート

  • SDS

概要
カタログ番号HV493016
説明
Tepoditamab (HV493016) is a research-grade recombinant antibody targeting CD371. Produced in mammalian cells with native-like glycosylation.
Highlights
  • ●Research Grade — For PK/PD studies, assay development, and ADA research.
  • ●Native Glycosylation — Mammalian expression ensures native-like patterns.
種反応性Human
アプリケーションELISA, Bioactivity: FACS, Functional assay, Research in vivo
宿主種Human
クローン性Monoclonal
アイソタイプIgG1-kappa
発現システム Mammalian cells
ターゲット CLEC12A, DCAL2, Dendritic cell-associated lectin 2, CLL-1, Myeloid inhibitory C-type lectin-like receptor, C-type lectin domain family 12 member A, CLL1, DCAL-2, C-type lectin-like molecule 1, MICL, CD371, T3E, T-cell surface antigen T3/Leu-4 epsilon chain, CD3e, CD3E, T-cell surface glycoprotein CD3 epsilon chain
エンドトキシンレベル < 10 EU/mg
純度 >95% purity as determined by SDS-PAGE.
精製 Protein A/G purified from cell culture supernatant.
アクセッション番号 Q5QGZ9 & P07766
形態 Liquid
保存バッファー 0.01M PBS pH 7.4

データシートのハードコピーまたはロット固有のCOAに記載された具体的なバッファー情報を参照してください。

安定性と保存 Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
別名Bispecific, MCLA-117, PB9122, 2044679-53-8
背景Tepoditamab (MCLA-117) is a bispecific monoclonal antibody that binds to CLEC12A of myeloid cells and CD3 of cytotoxic T cells. Among others, CLEC12A is a myeloid differentiation antigen. Tepoditamab (MCLA-117) kills AML leukaemia mother cells and AML leukaemia stem cells, induces T cell-mediated proliferative lysis of AML cells and can be used in acute myeloid leukaemia (AML) research.
注意事項 For research use only. Not suitable for clinical or therapeutic use.
Isotype Control Human IgG1 Recombinant Isotype Control Antibody (13R4) (HV080507)
イメージ
  • Anti-Human CD371/CLEC12A & CD3 epsilon Bispecific Reference Antibody (Tepoditamab, RUO)

    SEC-HPLC

    SEC-HPLC detection for Research Grade Tepoditamab.

  • Anti-Human CD371/CLEC12A & CD3 epsilon Bispecific Reference Antibody (Tepoditamab, RUO)

    Bioactivity

    Detects CD371/CLEC12A in indirect ELISAs.

  • Anti-Human CD371/CLEC12A & CD3 epsilon Bispecific Reference Antibody (Tepoditamab, RUO)

    SDS-PAGE

    SDS-PAGE for Research Grade Tepoditamab.

  • Anti-Human CD371/CLEC12A & CD3 epsilon Bispecific Reference Antibody (Tepoditamab, RUO)

    Flow cytometry

    Flow-cytometry APC using anti-human CD371 antibody. Untransfected cells (blue Histogram) and Transfected cells (Yellow Histogram) were stained with an APC anti-human CD371 monoclonal antibody (Catalog HV493016) at a concentration of 5 µg/ml for 30 mins at RT. After washing, cells analysed on a NovoCyte Flow Cytometer.

  • Anti-Human CD371/CLEC12A & CD3 epsilon Bispecific Reference Antibody (Tepoditamab, RUO)

    Flow cytometry

    Flow-cytometry PE using anti-human CD371 antibody. Untransfected cells (blue Histogram) and Transfected cells (Yellow Histogram) were stained with an PE anti-human CD371 monoclonal antibody (Catalog HV493016) at a concentration of 5 µg/ml for 30 mins at RT. After washing, cells analysed on a NovoCyte Flow Cytometer.

  • Anti-Human CD371/CLEC12A & CD3 epsilon Bispecific Reference Antibody (Tepoditamab, RUO)

    Flow cytometry

    Flow-cytometry FITC using anti-human CD371 antibody. Untransfected cells (blue Histogram) and Transfected cells (Yellow Histogram) were stained with an FITC anti-human CD371 monoclonal antibody (Catalog HV493016) at a concentration of 5 µg/ml for 30 mins at RT. After washing, cells analysed on a NovoCyte Flow Cytometer.

参考文献
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
レコメンデーション

お問い合わせ カスタムクォート、大量リクエストおよびその他の問題については

メール: [email protected]

ディストリビューターリスト